
Sodium Valproate + Valproic Acid Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Injection
Available Strengths: 100 mg/mL
Reference Brands: Depacon (Valproate IV)(US)
Category: Antipsychotropic Drugs
Sodium Valproate + Valproic Acid is available in Intravenous (IV) Injection and strengths such as 100 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Sodium Valproate + Valproic Acid is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Sodium Valproate + Valproic Acid can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Sodium Valproate + Valproic Acid combination is widely prescribed for the management of epilepsy, bipolar disorder, and migraine prophylaxis. This dual formulation ensures rapid and sustained release, improving therapeutic outcomes. Available in oral (200 mg, 300 mg, 500 mg) and injectable forms (100 mg/mL), it is marketed under popular brands like Epilim Chrono in the EU and Depakote equivalents in the US. Pharmaceutical exporters and distributors globally source this product from GMP-certified manufacturers due to its proven efficacy and consistent market demand. Ideal for neuropsychiatric B2B portfolios, it offers stable market opportunities for generics and branded suppliers.
Frequently Asked Questions
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View DetailsZuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View DetailsZuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View DetailsZuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers